Innovations and Progress in SpA Research, and New Treatment Options for SpA and Complications. Dr. Joerg Ermann.
Medication outcome trials and discussion of TNF inhibitors
Management of Spondyloarthritis beyond joint pain and prevalence of HLA-B27
Genetics of Ankylosing Spondylitis along with Covid-19 and Spondyloarthritis
What is HLA B27 and How does it relate to ankylosing spondylitis?
Understand the evolving definition,
immunology, genetics and classification of
ankylosing spondylitis (AS) and axial
spondyloarthritis (SpA)
Input your search keywords and press Enter.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.